Patent details

Basic Information

Publication number:

EP2893922

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP151506235

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Pharmaceutical formulations for the treatment of pulmonary arterial hypertension

French Title of Invention:

Formulations pharmaceutiques pour le traitement de l'hypertension artérielle pulmonaire

German Title of Invention:

Pharmazeutische Formulierungen zur Behandlung von pulmonaler arterieller Hypertonie

SPC Number:

Dates

Filing date:

09/01/2015

Grant date:

14/07/2021

EP Publication Date:

15/07/2015

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

14/07/2021

EP B1 Publication Date:

14/07/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

09/01/2022

Expiration date:

09/01/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

07/07/2021

 

 

Name:

Heart Biotech Pharma Limited

Address:

17 North Drive, Littleton, Winchester SO22 6QA, United Kingdom (GB)

Inventor

1

Name:

Yacoub, Magdi

Address:

United Kingdom (GB)

2

Name:

El Sherbiny, Ibrahim

Address:

Egypt (EG)

Priority

Priority Number:

201400412

Priority Date:

10/01/2014

Priority Country:

United Kingdom (GB)

Classification

IPC classification:

A61K 9/50; A61K 9/51; A61K 9/19; A61K 31/12; A61K 31/4965; A61K 31/5575; A61K 33/00; A61P 9/12; A61P 11/00;

Publication

European Patent Bulletin

Issue number:

202128

Publication date:

14/07/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages